Clinical Perspectives

Specialized Clinic for Bone Lesions and Bone Metastasis

The Sarcoma Program at Moffitt Cancer Center recently unveiled a new Bone Metastasis Clinic, a first of its kind in Florida and among only a handful...

Understanding MGUS: Why Early Monitoring Can Be Life-Changing

Mal Heme, Malignant Hematology, high-risk, patients Monoclonal Gammopathy of Undetermined Significance (MGUS)

From Clinical Trial to Standard of Care: Pembrolizumab Plus Chemoradiotherapy Available at Moffitt

The introduction of immunotherapy into the curative-intent setting has prompted a meaningful shift in cervical cancer treatment.

Now Enrolling: Novel Dendritic Cell Vaccines Immunotherapy Trial For HER2+ Breast Cancer

Dendritic cell vaccines study offers hope for a less toxic, more personalized approach for the treatment of HER2 breast cancer with less chemotherapy...

One of Only Five Multidisciplinary Cutaneous Lymphoma Clinics in U.S. is at Moffitt

Cutaneous lymphomas are a heterogenous group of lymphoproliferative disorders that present in the skin and are composed of malignant clonal T- or...

Q&A: Understanding Intralesional and Infusional Therapies for Metastatic Melanoma

Dr. Matthew Perez discusses intralesional and infusional therapies for metastatic melanoma.

Anaplastic Thyroid Cancer: A Rare but Urgent Diagnosis – What Referring Providers Need to Know

Recognizing, diagnosing and directing patients with suspected anaplastic thyroid cancer to multidisciplinary teams for timely and effective...

Guide on When to Refer Patients to the Endocrine Oncology Clinic at Moffitt

Moffitt's Endocrine Oncology Program offers a multidisciplinary approach to managing both common and rare endocrine tumors.

SONIC: Specialized Care for Immunotherapy Patients

Moffitt's SONIC program provides specialized care during the first cycles of bispecific antibodies when side effects and adverse events are most...

New FDA-Approved alloHSCT Options for AML Patients Now Available at Moffitt Cancer Center

Newly FDA-approved treosulfan combined with fludarabine as a preparative regimen for alloHSCT.

Sentinel Lymph Node Mapping for Uterine Cancer

Gynecologic oncologists at Moffitt Cancer Center are performing sentinel lymph node (SLN) mapping as a less-invasive alternative for uterine cancer...

A Primary Care Guide to Early Intervention For Brain Masses

When primary care providers and their patients face the complexity of a brain tumor diagnosis, Moffitt Cancer Center offers unparalleled expertise...

5 Reasons to Refer Your Patient for a Biopsy

Referring patients to cancer specialists for biopsies ensures that this vital first step is handled with the utmost precision and care.

The Role of Cardio-Oncology in Managing Cardiovascular Risks in Cancer Treatment

Moffitt Cancer Center's Cardio-Oncology Program is a unique, multidisciplinary initiative that focuses on managing the cardiovascular side effects of...

Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer: A Multidisciplinary Approach

Bladder preservation therapy is a well-established, evidence-based approach for select patients with muscle-invasive bladder cancer.